Статья
Изменения толщины комплекса интима-медиа сонной артерии у больных артериальной гипертензией с наличием и отсутствием метаболического синдрома
В обзоре проанализированы данные об исследованиях, посвященных изучению состояния толщины комплекса интима-медиа (ТИМ) общей сонной артерии у больных артериальной гипертонией с наличием и отсутствием метаболического синдрома; освещены вопросы патогенеза, факторов риска, оказывающих влияние на состояние ТИМ у больных с наличием и отсутствием метаболического синдрома.
1. Мясников А.Л. Гипертоническая болезнь и атеросклероз. Москва1965.
2. Диагностика и лечение артериальной гипертонии. Рекомендации ВНОК и Российского медицинского общества по артериальной гипертонии, Москва 2008.
3. Sorof JM, Alexandrov AV, Garami Z, et al. Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 2003; 18: 1020-4.
4. Litwin M, Trelewicz Z, Wawer Z, et al. Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 2004; 19: 767-74
5. Simon A, Gariepy J, Chironi G, et al. Intimamedia thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20: 159-69.
6. Gil TY, Sung CY, Shim SS, Hong YM. Intima-media thickness and pulse wave velocity in hypertensive adolescents. J Korean Med Sci 2008; 23(1): 35-40. '
7. PDAY (Pathobiological Determinants of Atherosclerosis in Youth) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 1990; 264: 3018-24.
8. Salonen RM, Nyyssnen K, Kaikkonen J, et al. Antioxidant Supplementation in Atherosclerosis Prevention Study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003; 107(7): 947-53.
9. Lorenz MW, von Kegler S, Steiimietz H, et al. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37(1): 87-92.
10. Salonen JT, Salonen R. Ultrasound В-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87(3 Suppl): 1156-65.
11. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction the Rotterdam Study. Circulation 1997; 96(5): 1432—7.
12. Chambless LE, Lolsom AR, Clegg LX, et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151(5): 478-87.
13. Iglesias del Sol A, Bots ML, Grobbee DE, et al. Carotid intima- media tliickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Em Heart J 2002; 23(12): 934-40.
14. Hollander M, HakAE, Koudstaal PJ, et al. Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 2003; 34(10): 2367-72.
15. Kitamura A, Iso H, Imano H, et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004; 35(12): 2788-94.
16. Rosvall M, Janzon L, Berglund G, et al. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 2005; 257(5): 430-7.
17. Murakami S, Otsuka K, Hotta N, et al. Common carotid intima-media thickness is predictive of all-cause and cardiovascular mortality in elderly community-dwelling people: Longitudinal Investigation for the Longevity and Aging in Hokkaido Comity (LILAC) study. Biomed Pharmacother 2005; 59(Suppl 1): S49— 53.
18. Tzou WS, Douglas PS, Srinivasan SR, et al. Increased subclinical atherosclerosis in young adults with metabolic syndrome. The Bogalusa Heart Study. JACC 2005; 46: 457—63.
19. Reneman RS, Meinders JM, Hoeks APG. Non-invasive ultra-sound in arterial wall dynamics in humans: what have we learned and what remains to be solved. Em Heart J 2005; 26: 960—6.
20. Okada M, Miida T, Hama H, et al. Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects. Intern Med 2000; 39(5): 362-8.
21. Tatsukawa M, Sawayama Y, Maeda N, et al. Carotid atherosclerosis and cardiovascular risk factors: a comparison of residents of a rural area of Okinawa with residents of a typical suburban area of Fukuoka, Japan. Atherosclerosis 2004; 172(2): 337-43.
22. Kawamoto R, Tomita H, Oka Y, et al. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med 2005; 44(12): 1232-8.
23. Berenson GS, Srinvasan SR, Boa W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart study. N Engl J Med 1998; 338: 1650-6.
24. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11:1245-9.
25. Zanchetti A, Crepaldi G, Bond MG, et al. Systolic and pulse blood pressures are assosiated in carotid intima-media tliickness in the moderately hypercholesterolaemic hypertension patient of the plaque hypertension lipid lowering/Italian Study PHYLLIS study group. J Hypertens 2001; 19(1): 79-88.
26. Liang YL, Sliiel LM, Teede H, et al. Effects of Blood Pressure, Smoking, and Their Interaction on Carotid Artery Structure and Function. Hypertension 2001; 37(1): 6-11.
27. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
28. Vazquez-Padron RI, Lasko D, Ii S, et al. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice. J Vase Smg 2004; 40: 1199-207.
29. Tracy RE. Medial thickness of coronary arteries as a correlate of atherosclerosis. Atherosclerosis 1998; 139: 11—9.
30. Olsen MH, Wachtell K, Neland K, et al. Losartan butnot atenolol reduce carotid artery hypertrophy in essential hypertension: a LIFE substudy. Blood Press 2005; 14: 177-83.
31. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial waif a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
32. Bigazzi R, Bianchi S, Nenci R, et al. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hrmi Hypertens 1995; 9(10): 827-33.
33. Cuspidi C, Lonati L, Sampieri L, et al. Left ventricular con-centric remodelling and carotid structural changes in essential hypertension. J Hypertens 1996; 14(12): 1441-6.
34. Vaudo G, Scliillaci G, Evangelista F, et al. Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension Am J Hypertens 2000; 13(4 Pt 1): 324-31.
35. Takiuslii S, Kamide K, Miwa Y, et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension J Himi Hypertens 2004; 18(1): 17-23.
36. Flynn JT. What Is the Significance of Increased Carotid Intima Media Thickness in Hypertensive Adolescents? Hypertension 2006; 48: 23-4.
37. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111: 61-6.
38. Диагностика и лечение метаболического синдрома. Рекомендации ВНОК. Москва 2007.
39. Shiwaku К, Nogi A, Kitajima К. et al. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 2005; 47(2): 126-35.
40. Nakanishi N, Takatorige T, Fukuda H, et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 2004; 64(1): 59-70.
41. Kawamoto R, Tomita H, Ohtsuka N, et al. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Tliromb 2007; 14(2): 78-85.
42. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002; 25(10): 1790-4.
43. Alexander CM, Landsman PB, Teutsch SM, Haffner SM; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defuied metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52(5): 1210—4.
44. Iglseder B, Cip P, Malaimare L, et al. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women thaninmen. Stroke 2005; 23(12): 934—40.
45. Poli A, Tremoli E, Colombo A, et al. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 1988; 70: 253-61.
46. Greenland P, Abrams J, Aurigenrma GP, et al. Prevention Conference V beyond secondary prevention identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden; Writing Group III. Circulation 2000; 101: E16-22.
47. Wang J-G, Staessen JA, Li Y, et al. Carotid Intima-Media Thickness and Antiliypertensive Treatment A Meta-Analysis of Randomized Controlled Trials. Stroke 2006; 37: 1933—40.
48. Lomi EM, YusufS, Dzavik, et al. for the SECURE Investigators. Effects of ramipril and Vitamin E on atherosclerosis: the Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and Vitamin E (SECURE). Circulation 2001; 103: 919-25.
49. Hosomi N, Mizushige K, Ohyama H, et al. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus. Stroke 2001; 32: 1539-45.
50. Hedblad B, Wikstrand J, Janzon L, et al. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the -Blocker Cholesterollowering Asymptomatic Plaque Study (BCAPS). Circulation 2001; 103: 1721-6.
51. Wrklund O, Hulthe J, Wikstrand J, et al. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke 2002; 33: 572—7.
52. Pitt B, Byington RP, Furberg CD, et al., for the PREVENT Investigators. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503-10.
53. Simon A, Garie py J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation 2001; 103: 2949-54.
54. Zanchetti A, Bond G, Heiuiig M, et al., on behalf of the ELSA investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002; 106: 2422-7.
55. Boutouyrie P, Bussy C, Hayoz D, et al. Local pulse pressure and regression of arterial wall hypertrophy dining long-term antiliypertensive treatment. Circulation 2000; 101: 2601—6.
56. Ludwig M, StapffM, RibeiroA, et al. Combination of the effects of losartan and atenolol on common carotid artery intima- media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther 2002; 24: 1175-93.
57. Pontremoli R, Viazzi F, Ravera M, et al. Long-term effect of nifedipine GITS and lisinopril on subclinical organ damage in patients with essential hypertension J Nephrol 2001; 14: 19-26.
58. Stanton AV, Chapman JN, Mayet J, et al. Effects of blood pres¬sure lowering with amlodipine or lisinopril on vascular structure ofthe common carotid artery. Clin Sci 2001; 101: 455-64.
59. Ariff B, Zambanini A, Vamadeva S, et al. Candesartan- and Atenolol-Based Treatments Induce Different Patterns of Carotid Artery and Left Ventricular Remodeling in Hypertension Stroke 2006; 37: 2381-4.
60. Benetos A, Gautier S, Lafleche A, et al. Blockade of angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans. J Vase Res 2000; 37: 8-15